Value-Based Healthcare—Demonstrating Value in an Era of Increased Scrutiny and Accountability

Value-based care, value-based contracting, outcomes-based contracting, risk-based contracting—the emergence of these strategies have left ...

Pharma Must Demonstrate Better Outcomes for Pay-Per-Performance

In the dramatically changing pharma industry, one key trend that overlays providers of care, ...

COVID-19: How are Payers Managing These Days?

If there’s one thing we know about payers, it’s they hate surprises. That’s why ...

Is Significant Change on the Horizon for Payers, Pricing, and Pharma?

Thanks to the 2020 presidential election, pharma companies can expect plenty of talk from ...

Two Key Questions About Payer Strategies in 2020

PM360 asked experts within market access strategies whether pricing regulation will impact 2020 and ...

The Next Chapter for Digital Therapeutics

Imagine you are a primary care physician (PCP) in a mid-sized Midwestern city. Over ...

The World’s Most Expensive Drug

Priced at a staggering $2.125 million per patient,  Zolgensma is now the world’s most ...